The migration of peripheral immune cells and splenocytes to the ischemic brain is one of the major causes of delayed neuroinflammation after permanent large vessel stroke. Other groups have demonstrated that leukemia inhibitory factor (LIF), a cytokine that promotes neural cell survival through upregulation of antioxidant enzymes, promotes an anti-inflammatory phenotype in several types of immune cells. The goal of this study was to determine whether LIF treatment modulates the peripheral immune response after stroke.
Pubmed ID: 30322390 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
THIS RESOURCE IS NO LONGER IN SERVICE, documented on February 1st, 2022. Software application for genetic analysis of classical biometric traits like blood pressure or height that are caused by a combination of polygenic inheritance and complex environmental forces. (entry from Genetic Analysis Software)
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis monoclonal targets Beta-actin
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis polyclonal targets IL-12
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets LMAN2
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis monoclonal targets Beta-actin
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis polyclonal targets IL-12
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets LMAN2
View all literature mentions